stopping and restarting glp-1 GLP-1s Safely: What to Expect How to Maintain Your Results Stopping GLP-1 Medications May Raise
Description
Saxenda for weight management is dosed higher (3 mg) than Victoza for diabetes (1.21.8 mg)

Baker, T

SeekPeptides members gain access to comprehensive long-term management strategies, including maintenance protocols , community support from others navigating the same challenges, and evidence-based guidance that evolves as new research emerges

GLP-1 receptor agonists have well-characterized safety profiles based on extensive use in diabetes and obesity management, but specific considerations apply when considering their use in patients with substance use disorders

Monitoring Side Effects Most side effects occur during the dose-escalation phase and are usually temporary